Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Parkinson's Disease
Parkinson's Disease
Neurocrine Terminates Parkinson's Deal with Voyager Following Clinical Hold
BioSpace
Wed, 02/3/21 - 10:57 am
Voyager Therapeutics
Parkinson's Disease
Neurocrine
clinical trials
Biogen tosses out Parkinson's hopeful cinpanemab, pays $75M for its syn
Fierce Biotech
Wed, 02/3/21 - 10:53 am
Biogen
earnings
Parkinson's Disease
cinpanemab
Medtronic Enrolls 1st Patient in Parkinson’s Disease Study
Medical Devices and Diagnostics Industry
Thu, 01/14/21 - 10:29 pm
Medtronic
Percept PC
Parkinson's Disease
devices
FDA hits Supernus with double whammy, handing biotech a CRL and RTF on same day
Endpoints
Tue, 11/10/20 - 10:40 am
Supernus
FDA
SPN-812
ADHD
SPN-830
Parkinson's Disease
Roche buys into Prothena... kind of
EP Vantage
Wed, 10/21/20 - 10:39 am
Roche
Prothena
prasinezumab
Parkinson's Disease
Seattle-based Athira, aiming for tough Alzheimer's and Parkinson's targets, raises $204M fo
Endpoints
Fri, 09/18/20 - 10:58 am
Athira Pharma
IPOs
Alzheimer's disease
Parkinson's Disease
Neurocrine launches Parkinson's therapy as COVID-19 related disruptions ease
Yahoo/Reuters
Mon, 09/14/20 - 10:18 am
Neurocrine Biosciences
drug launches
Parkinson's Disease
pandemic
COVID-19
Ogentys
Denali Therapeutics stock rockets into record territory after Biogen investment and collaboration
Marketwatch
Thu, 08/6/20 - 10:30 am
Denali Therapeutics
Biogen
Parkinson's Disease
AbbVie cans Voyager Alzheimer’s, Parkinson’s gene therapy pacts
Fierce Biotech
Tue, 08/4/20 - 11:07 am
AbbVie
Alzheimer's disease
Parkinson's Disease
Voyager Therapeutics
One-and-done gene therapy wipes out Parkinson's symptoms in mouse models
Fierce Biotech
Thu, 06/25/20 - 10:28 am
USCD
Parkinson's Disease
gene therapy
Sunovion Drug Gets FDA Nod for Treating Parkinson’s “Off” Episodes
Xconomy
Thu, 05/21/20 - 11:14 pm
Sunovion
FDA
Parkinson's Disease
Kynmobi
Pandemic Delays Neurocrine’s Drug Launch for Parkinson’s Disease
BioSpace
Sat, 05/16/20 - 11:49 am
Neurocrine
drug launches
Ongentys
Parkinson's Disease
pandemic
COVID-19
Fresh off positive Nuplazid data, Acadia adds new clinical drug from Vanderbilt in milestone-heavy deal
Endpoints
Fri, 05/8/20 - 10:43 am
Acadia Pharma
Vanderbilt
Nuplazid
drug development
Alzheimer's disease
Parkinson's Disease
Novartis spinout resTORbio reverse merges with T cell biotech after big PhIII failure
Endpoints
Wed, 04/29/20 - 10:31 am
Novartis
ResTORbio
M&A
Parkinson's Disease
Adicet Bio
FDA Approves Neurocrine Biosciences' Parkinson's Drug
Motley Fool
Mon, 04/27/20 - 07:35 pm
Neurocrine
FDA
Ongentys
Parkinson's Disease
Coronavirus puts on hold launch plans for Neurocrine's Parkinson's drug
Biopharma Dive
Sat, 04/25/20 - 12:12 am
Neurocrine
Parkinson's Disease
drug launches
COVID-19
pandemic
Cerevance Nabs $45 Million in Funding to Support CNS Disease Research
BioSpace
Tue, 04/14/20 - 10:08 pm
Cerevance
CNS
Alzheimer's disease
Parkinson's Disease
Aspen Neuro Adds $70M to Test Parkinson’s Cell Therapy in the Clinic
Xconomy
Wed, 04/1/20 - 09:30 am
Aspen Neuro
Parkinson's Disease
cell therapy
Lundbeck adds a Parkinson's flop to its list of setbacks, writing off a $1.1 billion deal on mid-stage failure
Endpoints
Mon, 03/30/20 - 10:47 am
Lundbeck
R&D
Parkinson's Disease
foliglurax
Swiss bio Addex halts Parkinson's test as trial delays tick up on COVID-19 disruption
Fierce Biotech
Wed, 03/18/20 - 10:11 am
Addex Therapeutics
Parkinson's Disease
dipraglurant
COVID-19
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »